Columbus-based OhioHealth has tested an AI tool that flags echocardiogram results to accelerate evaluation and treatment of valvular heart disease. Findings from the ALERT trial were published March ...
ASX-listed Echo IQ has obtained regulatory approval in the United States for its AI-driven solution that supports structural heart disease diagnosis. Two years since coming to the US, the company has ...
(MENAFN- ABN Newswire) Sydney, April 22, 2026 AEST (ABN Newswire) - In this episode of The Ellis Martin Report, CEO Dustin Haines of Echo IQ Limited (ASX:EIQ ) (ECHQF:OTCMKTS ) discusses how ...
Thousands of patients sent for vital heart scans may be undergoing unnecessary first-line tests that fail to deliver clear ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
BACKGROUND: The World Health Organization recommends echocardiographic screening and secondary prophylaxis for rheumatic ...
Magnetic resonance imaging (MRI) scans of the heart could help to detect a life-threatening heart disease and enable clinicians to better predict which patients are most at risk, according to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results